Page last updated: 2024-11-04

sulfinpyrazone and Embolus

sulfinpyrazone has been researched along with Embolus in 3 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weiss, M1
Barnett, HJ1
Verstraete, M1

Reviews

2 reviews available for sulfinpyrazone and Embolus

ArticleYear
The pathophysiology of transient cerebral ischemic attacks.
    The Medical clinics of North America, 1979, Volume: 63, Issue:4

    Topics: Arteriosclerosis; Aspirin; Carotid Arteries; Cerebrovascular Disorders; Cholesterol; Embolism; Endoc

1979
[Prophylactic value of platelet anti-aggregants in coronary disease].
    La Clinica terapeutica, 1979, Oct-31, Volume: 91, Issue:2

    Topics: Anticoagulants; Arteriosclerosis; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Embolism; Hea

1979

Other Studies

1 other study available for sulfinpyrazone and Embolus

ArticleYear
Potentiation of coumarin effect by sulfinpyrazone.
    Lancet (London, England), 1979, Mar-17, Volume: 1, Issue:8116

    Topics: Coumarins; Drug Synergism; Drug Therapy, Combination; Embolism; Humans; Middle Aged; Postoperative C

1979